What is definitely true about GHK-Cu?

That it binds copper(II) with high affinity through a defined site, forming a discrete blue complex. That chemistry is not in dispute.

Is there human clinical evidence?

Limited. The literature is predominantly in vitro and animal work.

How does the evidence compare to other research peptides?

Better grounded than DSIP, which has no receptor and an unresolved central claim; far less than the incretins with their large randomised trials.

GHK-Cu in the Published Literature

The short answer

The literature reports effects on extracellular matrix biosynthesis, antioxidant activity through copper delivery to superoxide dismutase, wound-repair models and broad gene-expression modulation. It is predominantly in vitro and animal work, with a notable concentration of authorship.

Key facts

Main reported areas: Matrix biosynthesis, antioxidant, gene expression
Evidence type: Predominantly in vitro and animal
Mechanism established: Copper binding: not in doubt
Mechanism proposed: Copper delivery to cuproenzymes
Receptor: None characterised
Authorship: Concentrated in one long programme

What is solidly established

That GHK binds copper(II) with high affinity through a defined ATCUN-type site, forming a discrete complex with its own CAS registration and characteristic blue colour. This is straightforward coordination chemistry, independently verifiable, and nothing in the literature disputes it.

What is well supported

That the complex affects matrix biosynthesis in cell culture, and that copper delivery to lysyl oxidase and superoxide dismutase is a coherent mechanism for a meaningful portion of that. The chemistry and the enzyme dependencies are independently known, which makes this more than an isolated observation.

Research material referenced

GHK-Cu 100mg, third-party HPLC tested

Buy GHK-Cu · £24.99

What is reported but weakly grounded

Broad gene-expression modulation, real as a measurement, but from Connectivity Map analysis of cultured cell lines, and several steps upstream of function. Interactions with growth-factor signalling, which lack a defined mechanism. And the anti-ageing framing, which rests on an age-decline correlation rather than on intervention evidence.

What is absent

A characterised receptor. Substantial human clinical data. Independent replication of the broader claims by unconnected groups. None of these absences refutes anything; together they define how far the evidence currently reaches.

How the evidence compares

GHK-Cu is better grounded than DSIP, which has no gene, no receptor and an unresolved central claim. It is less well grounded than the incretins, which have large randomised trials with hard endpoints. It sits where most research peptides sit: real chemistry, plausible mechanism, model-system evidence, and a gap before anything can be said about people.

How to search it

PubMed indexes the field under GHK-Cu and under glycyl-histidyl-lysine; prezatide and copper tripeptide-1 surface further records. Checking the model system and the author list on any given paper is the fastest way to establish what kind of evidence it offers and how independent it is.

Frequently asked questions

What is definitely true about GHK-Cu?: That it binds copper(II) with high affinity through a defined site, forming a discrete blue complex. That chemistry is not in dispute.
Is there human clinical evidence?: Limited. The literature is predominantly in vitro and animal work.
How does the evidence compare to other research peptides?: Better grounded than DSIP, which has no receptor and an unresolved central claim; far less than the incretins with their large randomised trials.

Extended research context

The GHK-Cu (Copper Peptide) deep dive

Deep dive: why the copper ion matters

The GHK tripeptide (Gly-His-Lys) coordinates a Cu²⁺ ion through the imidazole nitrogen of histidine, the terminal α-amino group of glycine, and a deprotonated peptide-bond nitrogen. This near-square-planar geometry is what gives the complex its characteristic deep-blue colour and its redox-modulating chemistry. Uncomplexed GHK is a different molecule pharmacologically. Nearly every peer-reviewed study attributes activity to the copper-bound form, which is why suppliers ship the pre-complexed GHK-Cu rather than plain GHK.

GHK-Cu in the transcriptomic literature

The most-cited modern papers on GHK-Cu come from the Pickart & Margolina group and independent transcriptomic re-analyses. GHK-Cu has been reported to modulate expression of >4,000 human genes at nanomolar concentrations in Broad Institute Connectivity Map re-analyses, including genes involved in DNA repair, antioxidant defence, and ECM remodelling. This gene-signature-level activity is the reason GHK-Cu appears in so many research reviews outside of dermatology.

Analytical fingerprinting of GHK-Cu

On reverse-phase HPLC, GHK-Cu elutes as a well-defined peak; free GHK and copper-free peptide impurities are distinguishable. UV-Vis at ~520 nm confirms the copper d-d transition band. Reputable suppliers publish both HPLC (≥98% area) and mass-spec identity (~340 Da complex, 340.4 free peptide) on the batch CoA.

Research applications

▸In vitro fibroblast and keratinocyte gene-expression studies
▸ECM turnover assays (collagen, elastin, decorin, MMP profiling)
▸Wound-healing scratch assays in cell culture models
▸Antioxidant-mechanism studies (copper redox modulation)
▸Formulation R&D: cosmetic and topical carrier compatibility research

Handling checklist

✓Store lyophilised vial at 2–8 °C, protected from light
✓Reconstitute with bacteriostatic or sterile water; expect a blue-tinted solution
✓Avoid contact with reducing agents (ascorbic acid destabilises Cu²⁺)
✓Aliquot reconstituted solution for freeze/thaw minimisation
✓Verify blue colour and CoA HPLC ≥98% before use

Common research-handling mistakes

Learnt from thousands of researcher orders across our UK labs.

✗ Buying GHK without copper

Fix: Confirm the CoA reads GHK-Cu (copper-bound); free GHK is a different pharmacology.

✗ Mixing with vitamin C in solution

Fix: Ascorbate reduces Cu²⁺ to Cu⁺ and destabilises the complex, keep them separate.

✗ Exposing to sunlight

Fix: Store in amber vial or foil-wrapped container at 2–8 °C.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

UKP

Written and reviewed by

The UK Peptides Editorial Team · Research library, UK Peptides

The editorial team is responsible for supplier selection, batch release decisions and the content published in this research library. Every article here is sourced to primary literature and every product page to a signed third-party certificate. Corrections are made in place and the review date updated.

How we write and check this content Report a factual error in this article

More GHK-Cu (Copper Peptide) articles

Popular across the research hub

One flagship guide from every other research category.

← Back to Forum